Approval for euflexxa (1% sodium hyaluronate). this device is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservativenon-pharmacologic therapy and to simple analgesics (e. g., acetaminophen).